Home›People›Gabriele Corso
Gabriele Corso

Gabriele Corso

Co-founder and CEO of Boltz, PBC

ExecutiveDirector
Updated Nov 7, 2026·Latest SEC filing Oct 22, 2026·Suggest an edit

About Gabriele Corso

Gabriele Corso is the co-founder and chief executive officer of Boltz, PBC. Boltz is a public-benefit AI research company. Pharmaceutical and biotech organizations use its models for biomolecular modeling and design. Corso is also the company's president and a director.

He was part of the team behind Boltz-1, an open-source model the MIT Jameel Clinic announced on November 16, 2024.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Gabriele Corso in the role, so the role may have started earlier or lasted longer.

Boltz, PBC Current
Co-founder and CEO, director
2026 – Present · Boston, MA
Boltz builds open-source and proprietary AI models, plus a platform and API, to predict and design small molecules and proteins.

Key Colleagues at Startups

The people Gabriele Corso works with at each company, as listed on that company's latest Form D.

Boltz, PBC · Form D, Oct 22, 2026
SP
Saro Passaro
Director
Jeremy Wohlwend
Jeremy Wohlwend
Executive officer and director
DR
Dylan Reid
Director
AH
Andrew Hedin
Director

Gabriele Corso in the News

Sources

  1. SECBoltz, PBC Form D, filed Oct 22, 2026
  2. companyBoltz and Bristol Myers Squibb announcement
  3. companyBoltz and Takeda announcement
  4. wireBoltz and Pfizer announcement (PR Newswire)
  5. mitMIT Jameel Clinic: Introducing Boltz-1